When Antidepressants Leave Lasting Damage: Living with Post-SSRI/SNRI Sexual Dysfunction
/For many people, sexuality is a very important aspect of life. It is integral to our personal identity, our quality of life, and the ways we connect with other human beings.
So what happens to those of us whose sexuality is removed or severely diminished by a medication? What about when that eliminated or compromised sexuality does not recover, even after cessation of that medication? For people with long-term Post-SSRI/SNRI Sexual Dysfunction (PSSD), the impacts to our lives can be devastating.
SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors) are classes of psychoactive pharmaceuticals used to treat depression and other mental health conditions. They come under many names and are known for causing reduced libido during treatment for many people. (Higgins, Nash & Lynch 2010) SSRIs are more notorious for this side-effect then SNRIs, but both can have an impact on sexual functioning. For many users of antidepressants, the sexual side-effects are the reason they eventually discontinue the drug, with or without medical supervision (Francois D 2017).
When patients bring their concerns about sexual functioning while on antidepressants to their doctor or psychiatrist, they are almost universally told that their sexuality will return to normal after tapering off the drug. Unfortunately, recent data has emerged showing that this is not always true. (Reisman 2020) (Bahrick 2008) Some patients continue to experience sexual dysfunction for weeks, months, or years after withdrawing from such treatment. Sometimes, these symptoms only emerge after the patient has tapered off the medication.
“I am left with a near total lack of sensation up until orgasm - an orgasm that often feels like it's a third of the strength that it once was. I used to daydream about sex quite often. Now I have virtually no sexual thoughts, even after going weeks without masturbating.” –Mark, age 32, PSSD for 7 years
Even more alarming are the patients coming forward who have experienced a total elimination of their sexuality that persists indefinitely. These patients report a severe or total loss of erotic sensation in their genitals, sometimes to the point of tactile numbness. Some patients have been unable to experience attraction, arousal, or orgasm for years or even decades, with no other discernable cause apart from treatment with antidepressants.
“In addition to the loss of libido and sexual sensation (numbness of genitalia and other erogenous zones), my general sensitivity to the pleasure of touch has declined. A caress on bare skin registers as little more than pressure. Again, there is a feeling of numbness, as if there is some kind of barrier between my skin and the source of contact… When I brought some literature on PSSD to my former psychiatrist, she refused to even look at it, dismissing it—and my concerns—as “ridiculous.” I have also raised it with my current GP, but he’s not interested in hearing about it.” - Ellen, age 48, PSSD for 15 years
Furthermore, these long-term impacts on sexual functioning are often accompanied by emotional and cognitive symptoms such as “brain fog” or reduced emotional range, commonly referred to as “emotional blunting.” (Opbroek et al 2002) A common variant of this is the reduced or removed ability to experience emotions of romantic attachment. (Fisher, 2007) Patients have reported feeling permanently emotionally flat or experiencing memory and sleeping problems that began at the same time as their sexual dysfunction. For some people, these emotional and cognitive symptoms can be equally or even more difficult to cope with than the sexual dysfunction.
The prevalence of these symptoms among patients treated with SSRIs and SNRIs is unknown, as are the underlying causes, risk factors, and recovery rates. There is currently no known effective treatment. (Bala 2017)
What is known is that many people who experience PSSD find it extremely debilitating to their relationships and overall quality of life. The loss of one’s sexuality and the associated symptoms is a traumatic experience and can lead to increased depression, relationship dissolution, and suicide.
“To say that PSSD has negatively impacted my life would be an understatement of tremendous magnitude. The implications of this cannot be remotely imagined by a normal person. In my opinion, healthy human sexuality is a requisite for being able to properly perceive and navigate the world, even things that seem totally removed from sexuality. It fuels many aspects of our personality and behavior without the average human being even realizing it – until it is taken away.” - Jake, age 29 (PSSD for 11 years, since age 18)
For many years, the medical community was sceptical of the existence of PSSD. Patients were frequently told that their symptoms were a result of their mental health condition, despite the fact they had never experienced such symptoms prior to antidepressant treatment. That view is now shifting due to the dedicated work of researchers, whose documentation of PSSD cases led to the recognition of PSSD as an iatrogenic (meaning caused by medical treatment) condition by the European Medicines Agency. (Healy, D. 2020). Though not yet recognised outside of Europe, doctors around the world are slowly becoming more aware of the risk of Post SSRI/SNRI Sexual Dysfunction. Health Canada put SSRIs and SNRIs under review for long-term sexual dysfunction in 2018 and the report is expected later this year. (Health Canada 2018)
“One major issue with the experience of developing PSSD was the lack of information available to the consumer of antidepressants. I was not informed of the possibility of these side effects persisting – I did my due diligence in looking up the medications, reading pamphlets on the side effects, and talking to pharmacists and doctors, but it was never mentioned that these side effects could persist; for simplicity’s sake, I was “chemically castrated,” without my consent, and without any sort of warning. Being completely blindsided by the persistent side effects has made this experience that much more devastating.” - Andrew, age 29, PSSD for 2 years
Raising awareness is the first step towards achieving research into the causes, rates, and potential treatments of this disorder. Patient activist groups are now springing up around the world to advocate for recognition and research.
Our group PSSD Canada was established in May 2020 to advocate for PSSD sufferers in our home country of Canada and internationally. We are not anti-psychiatry or against the use of antidepressant medication, but we advocate for greater research, awareness, and transparency of the potential health risks so that patients can be informed of the risks and benefits before choosing this treatment option. Please view our mission statement here: https://pssdcanada.squarespace.com/mission-statement
We collect personal stories, academic sources, and professional statements of support on our mwebsite www.pssdcanada.squarespace.com
If you have questions or are interested in getting involved, please get in touch: pssdcanada@gmail.com
Emily Grey, Co-ordinator PSSD Canada
References
Bahrick, A. S. (2008). Persistence of sexual dysfunction side effects after discontinuation of antidepressant medications: Emerging evidence. The Open Psychology Journal, 1, Article 42-50. https://pdfs.semanticscholar.org/c8e7/5efa92141ab40afd2a83da435c39bc8371cd.pdf;
Francois D, Levin A, Kutscher E, Asemota B. Antidepressant-Induced Sexual Side Effects: Incidence, Assessment, Clinical Implications, and Management. Psychiatr Ann. 2017; 47: 154-160; https://www.healio.com/psychiatry/journals/psycann/2017-3-47-3/%7Bdecf437a-8f22-446c-923a-19e84670a187%7D/antidepressant-induced-sexual-side-effects-incidence-assessment-clinical-implications-and-management
Bala A, Nguyen HMT, Hellstrom WJG. Post-SSRI Sexual Dysfunction: A Literature Review. Sex Med Rev. 2018;6(1):29-34. doi:10.1016/j.sxmr.2017.07.002; Retrieved from https://www.researchgate.net/publication/318839298_Post-SSRI_Sexual_Dysfunction_A_Literature_Review
Healy D. (2020) Antidepressants and sexual dysfunction: a history. Journal of the Royal Society of Medicine. 113(4):133-135. Retrieved from https://journals.sagepub.com/doi/full/10.1177/0141076819899299
Fisher, H., & Thomson Jr, J.A. (2007) Lust, Romance, Attraction, Attachment: Do the side-effects of serotonin-enhancing antidepressants jeopardize romantic love, marriage and fertility? Evolutionary Cognitive Neuroscience. SM Platek, JP Keenan and TK Shakelford (Eds.). Cambridge, MA: MIT Press Pp. 245-283; Retrieved from http://helenfisher.com/downloads/articles/18ecn.pdf
Health Canada, 2018, Safety and effectiveness reviews started between 2018-11-01 and 2018-11-30 Retrieved from https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/new.html
Higgins, A., Nash, M., & Lynch, A. M. (2010). Antidepressant-associated sexual dysfunction: impact, effects, and treatment. Drug, healthcare and patient safety, 2, 141–150. https://doi.org/10.2147/DHPS.S7634;
Opbroek, A., Delgado, P.L., Laukes, C., McGahuey, C., Katsanis, J., Moreno, F.A., & Manber, R., Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses?, International Journal of Neuropsychopharmacology, Volume 5, Issue 2, June 2002, Pages 147–151, Retrieved from https://doi.org/10.1017/S1461145702002870
Reisman Y. (2020) Post-SSRI sexual dysfunction BMJ 2020;368:m754; Retrieved from https://www.bmj.com/content/368/bmj.m754?utm_source=twitter&utm_medium=social&utm_term=hootsuite&utm_content=sme&utm_campaign=usage